Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients
暂无分享,去创建一个
C. Marquette | S. Leroy | J. Benzaquen | P. Hofman | V. Hofman | J. Mouroux | E. Long-Mira | M. Ilié | S. Heeke | O. Bordone | C. Cohen | S. Lalvée | V. Tanga | V. Lespinet | Camille Ribeyre
[1] S Senan,et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] A. Czirók,et al. Cell Dispersal Influences Tumor Heterogeneity and Introduces a Bias in NGS Data Interpretation , 2017, Scientific Reports.
[3] Rafal Dziadziuszko,et al. Alectinib versus Crizotinib in Untreated ALK‐Positive Non–Small‐Cell Lung Cancer , 2017, The New England journal of medicine.
[4] Anne-Mette K. Hein,et al. Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform , 2017, BMC Cancer.
[5] C. Marquette,et al. NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype? , 2017, Expert review of anticancer therapy.
[6] Yoon-La Choi,et al. Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests , 2017, Journal of pathology and translational medicine.
[7] Yi Kong,et al. Use of the GeneReader NGS System in a clinical pathology laboratory: a comparative study , 2017, Journal of Clinical Pathology.
[8] Steven E. Schild,et al. Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology , 2017 .
[9] P. Brousset,et al. High-throughput detection of clinically targetable alterations using next-generation sequencing , 2017, Oncotarget.
[10] Christoph Endrullat,et al. Standardization and quality management in next-generation sequencing , 2016, Applied & translational genomics.
[11] G. Sica,et al. Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies. , 2016, The Journal of molecular diagnostics : JMD.
[12] C. Schumann,et al. Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors. , 2015, The oncologist.
[13] S. Peters,et al. BRAF Alterations as Therapeutic Targets in Non–Small-Cell Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[14] R. McCormack,et al. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII). , 2015, American journal of cancer research.
[15] M. Koudijs,et al. Comparison of next-generation sequencing and mutation-specific platforms in clinical practice. , 2015, American journal of clinical pathology.
[16] Leslie Cope,et al. Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing. , 2014, American journal of clinical pathology.
[17] Rashmi Kanagal-Shamanna,et al. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. , 2013, The Journal of molecular diagnostics : JMD.
[18] R. Sinke,et al. Targeted Next‐Generation Sequencing can Replace Sanger Sequencing in Clinical Diagnostics , 2013, Human mutation.
[19] Tina Hambuch,et al. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. , 2012, The Journal of molecular diagnostics : JMD.
[20] L. Spaggiari,et al. Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[21] P. Hofman,et al. Usefulness of tissue microarrays for assessment of protein expression, gene copy number and mutational status of EGFR in lung adenocarcinoma , 2010, Virchows Archiv.
[22] Hadley Wickham,et al. ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .
[23] S. Gabriel,et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.
[24] Renato Martins,et al. Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.
[25] Hong-lei Chen,et al. Comparison of two methods to extract DNA from formalin-fixed, paraffin-embedded tissues and their impact on EGFR mutation detection in non-small cell lung carcinoma. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[26] Savita Shrivastava,et al. Validation of a next-generation sequencing assay for clinical molecular oncology. , 2014, The Journal of molecular diagnostics : JMD.
[27] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .